Cargando…

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396419/ https://www.ncbi.nlm.nih.gov/pubmed/25897201 http://dx.doi.org/10.2147/DDDT.S84395

Ejemplares similares

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus
por: Cogollo, Estafania, et al.
Publicado: (2015)

Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
por: Pitsiu, Maria, et al.
Publicado: (2023)

Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”
por: Zhou, Shaolan, et al.
Publicado: (2021)

Corrigendum to “Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study”
por: Kroese, Sylvia J., et al.
Publicado: (2022)

Corrigendum to “A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, and Associated Immunological Profiles”
por: Bougea, Anastasia, et al.
Publicado: (2016)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Corrigendum to “Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-Analysis”
por: Lee, Jiwon M., et al.
Publicado: (2020)

An Exploratory Dose-Escalating Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Atacicept in Patients with Systemic Lupus Erythematosus
por: Pena-Rossi, C, et al.
Publicado: (2009)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
Publicado: (2018)

Integrated safety profile of atacicept: an analysis of pooled data from the atacicept clinical trial programme
por: Gordon, Caroline, et al.
Publicado: (2019)

Corrigendum to Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets
Publicado: (2015)

Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus
por: Al Rayes, Hanan, et al.
Publicado: (2014)

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
por: Isenberg, David, et al.
Publicado: (2015)

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
por: Ginzler, Ellen M, et al.
Publicado: (2012)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Corrigendum to “Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births”
por: Kroese, S. J., et al.
Publicado: (2022)

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty‐Four–Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Arm, Phase IIb Study
por: Merrill, Joan T., et al.
Publicado: (2018)

Corrigendum to “Natural Treatment Systems as Sustainable Ecotechnologies for the Developing Countries”
por: Mahmood, Qaisar, et al.
Publicado: (2018)

Corrigendum: ICTV Virus Taxonomy Profile: Ophioviridae
por: García, María Laura, et al.
Publicado: (2018)

Corrigendum: ICTV Virus Taxonomy Profile: Chrysoviridae
por: Ghabrial, Said A., et al.
Publicado: (2018)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015)

Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum]
Publicado: (2016)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum]
Publicado: (2015)

Site-specific N- and O-glycosylation analysis of atacicept
por: Stavenhagen, Kathrin, et al.
Publicado: (2019)

Kinetics of free and ligand-bound atacicept in human serum
por: Eslami, Mahya, et al.
Publicado: (2022)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Corrigendum to “Potential Extensions of the US FRAX Algorithm”
por: Osteoporosis, Journal of
Publicado: (2018)

Corrigendum: treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy
Publicado: (2023)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [Corrigendum]
Publicado: (2015)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

Corrigendum to “Transcriptome Profiling across Five Tissues of Giant Panda”
por: Li, Feng, et al.
Publicado: (2022)

Corrigendum: Inheritance of pheromone profiles from aged D. melanogaster
Publicado: (2022)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum]
Publicado: (2016)

Corrigendum to: Rotor mechanism and its mapping in atrial fibrillation
Publicado: (2023)

Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]
Publicado: (2021)

Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum]
Publicado: (2022)

Corrigendum to “A Clinical Decision Support System for the Diagnosis, Fracture Risks and Treatment of Osteoporosis”
por: Halldorsson, Bjarni V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6m8cic8fof29iam8lda7jfji08